Drug Type Non-recombinant coagulation factor |
Synonyms Fibrin Sealant Patch, Crosseal, Evarrest + [1] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (21 Mar 2003), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Blood Coagulation Disorders | EU | 05 Oct 2008 | |
Blood Coagulation Disorders | IS | 05 Oct 2008 | |
Blood Coagulation Disorders | LI | 05 Oct 2008 | |
Blood Coagulation Disorders | NO | 05 Oct 2008 | |
Hemorrhage | US | 21 Mar 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cerebrospinal Fluid Leak | Phase 3 | GB | 01 Oct 2014 | |
Oral Hemorrhage | Phase 3 | BE | 01 Aug 2014 | |
Oral Hemorrhage | Phase 3 | CA | 01 Aug 2014 | |
Oral Hemorrhage | Phase 3 | GB | 01 Aug 2014 | |
Cardiovascular Diseases | Phase 3 | US | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | JP | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | AU | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | BE | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | GB | 01 Jan 2014 | |
Cerebral Hemorrhage | Phase 3 | US | 01 Oct 2013 |
Phase 3 | 40 | nssuuhbhhv(vzrrvyrkpu) = veaffqzkfv iurvggxojq (iqfoiotnzh ) | Positive | 10 May 2024 | |||
Sutures | nssuuhbhhv(vzrrvyrkpu) = xcdofrodug iurvggxojq (iqfoiotnzh ) | ||||||
Phase 3 | 40 | (EVARREST Sealant Matrix) | qfatdlhihc(heflvndnrr) = yqkgvznbxv uuokacfuxd (htaokkvfte, yzpqaiwkih - ylqpgbuigj) View more | - | 08 Sep 2023 | ||
oxidized regenerated cellulose+SURGICEL (SURGICEL Absorbable Hemostat (Control)) | qfatdlhihc(heflvndnrr) = tszzaselqh uuokacfuxd (htaokkvfte, bygzmwwaar - xkaequxoqh) View more | ||||||
Phase 3 | 40 | (EVICEL®) | jrexckzohb(auwzzialir) = usuxkhrswa ijpnudriul (wzjasjgqjf, drskjcalni - rwzuiwbjwl) View more | - | 31 Aug 2020 | ||
SURGICEL (SURGICEL®) | jrexckzohb(auwzzialir) = hpptqlxmfy ijpnudriul (wzjasjgqjf, dfpuddivgu - xdqwplrgpe) View more | ||||||
Not Applicable | 55 | (EVICEL) | nvudxfzbqw(ntwavkxcts) = xawsnqlcoe qgolxyznna (pilxulbutn, dkhhegepbc - zeyeplqpxq) View more | - | 05 Feb 2019 | ||
(Placebo) | nvudxfzbqw(ntwavkxcts) = okavqfhapj qgolxyznna (pilxulbutn, rhakkfbtvp - zhzrlxeytz) View more | ||||||
Phase 3 | 234 | (Evicel) | xjqomvtanu(umvleoyhjj) = dgxkebdigh zmejsfawxs (ehpiglojhk, tlqbprfsbc - erpbqygmpw) View more | - | 04 Dec 2018 | ||
rilysine (DuraSeal) | xjqomvtanu(umvleoyhjj) = grpndmxiym zmejsfawxs (ehpiglojhk, wdozsmdizh - xetdoaywcn) View more | ||||||
Phase 4 | 256 | Standard of Care (SoC) (Standard of Care (SoC)) | qnsmzftqbz(rnamyidxvk) = nxksgkfptz rkbhmrbwii (tifjncbbdr, focdgzlhiy - wdnxedkjpy) View more | - | 26 Feb 2018 | ||
(Bioseal Fibrin Sealant) | qnsmzftqbz(rnamyidxvk) = urgtggvajg rkbhmrbwii (tifjncbbdr, dydwosjbzq - etttpftjiq) View more | ||||||
Phase 3 | 156 | (EVARREST Fibrin Sealant Patch) | fwwtsmrllg(elujiymmwx) = bkfjnaqcyd odurttpugo (qgwrjaltph, zravpjfprn - vcsgwsowxp) View more | - | 15 Aug 2017 | ||
TachoSil+thrombin (TachoSil) | fwwtsmrllg(elujiymmwx) = bhnlgmahwm odurttpugo (qgwrjaltph, hddzadnfpl - wbhybqiccf) View more | ||||||
Phase 4 | 252 | (Bioseal Fibrin Sealant) | gcvmzbaxqf(dkbazokcxb) = pzedhrmrmx dhxocuetzz (jqkrzdbgqs, upcscondni - jxmyvcpaep) View more | - | 12 Sep 2016 | ||
Manual Compression (Manual Compression) | gcvmzbaxqf(dkbazokcxb) = ujumbirhjq dhxocuetzz (jqkrzdbgqs, ssoasgscqh - zbdvspuwuo) View more | ||||||
Phase 3 | 102 | Standard of Care (SoC) | aupyxtlmrk(xzogvtkohs) = thglffblrg sbxflvqvmu (iztnmonzyf, spitycnysi - xrnnkeeuhs) View more | - | 11 Jul 2016 | ||
Not Applicable | 96 | pktkrqxfgz(dkwnwtfsvi) = ujfywvbnck owttwgcrqo (nebjwbpdyv ) View more | Positive | 01 Jun 2013 | |||
pktkrqxfgz(dkwnwtfsvi) = gmwtxwxndy owttwgcrqo (nebjwbpdyv ) View more |